BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27200096)

  • 1. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.
    Thapa R; Wilson GD
    Stem Cells Int; 2016; 2016():2087204. PubMed ID: 27200096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
    Wang SJ; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression.
    Bourguignon LYW
    Front Oncol; 2019; 9():492. PubMed ID: 31293964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 as a tumor biomarker and therapeutic target.
    Xu H; Niu M; Yuan X; Wu K; Liu A
    Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu P; Pretta A; Aimola V; Cau F; Mariani S; D'Agata AP; Codipietro C; Rizzo D; Dell'Utri V; Sanna G; Moledda G; Cadoni A; Lai E; Puzzoni M; Pusceddu V; Castagnola M; Scartozzi M; Faa G
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics.
    Chaudhry GE; Akim A; Naveed Zafar M; Safdar N; Sung YY; Muhammad TST
    Adv Pharm Bull; 2021 May; 11(3):426-438. PubMed ID: 34513617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.
    Bourguignon LY
    Int J Mol Sci; 2016 Apr; 17(4):517. PubMed ID: 27070574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Hyaluronan-CD44 Signaling Promotes miRNA-21 Expression and Interacts with Vitamin D Function during Cutaneous Squamous Cell Carcinomas Progression Following UV Irradiation.
    Bourguignon LY; Bikle D
    Front Immunol; 2015; 6():224. PubMed ID: 26029210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
    Chanmee T; Ontong P; Kimata K; Itano N
    Front Oncol; 2015; 5():180. PubMed ID: 26322272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
    Bourguignon LY; Zhu D; Zhu H
    Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
    Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
    Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 and its implication in neoplastic diseases.
    Xu Y; Bai Z; Lan T; Fu C; Cheng P
    MedComm (2020); 2024 Jun; 5(6):e554. PubMed ID: 38783892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
    Hiraga T; Ito S; Nakamura H
    Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.